Literature DB >> 15467743

Mxi1-SRalpha: a novel Mxi1 isoform with enhanced transcriptional repression potential.

Claire Dugast-Darzacq1, Melinda Pirity, Jennifer K Blanck, Alexis Scherl, Nicole Schreiber-Agus.   

Abstract

Mxi1 belongs to the Myc/Max/Mad network of proteins that have been implicated in the control of multiple aspects of cellular behavior. Previously, we had reported that the mouse mxi1 gene gives rise to two distinct transcript forms that can encode proteins with dramatically different functional abilities. The Mxi1-SR protein (here termed Mxi1-SRbeta) can interact with Sin3/histone deacetylase and function as a potent transcriptional repressor and growth suppressor, while the Mxi1-WR protein lacks these activities. Here, we describe a new mxi1-derived transcript form (termed mxi1-SRalpha) whose expression is governed by its own promoter, resulting in a spatiotemporally distinct expression profile from that of the highly related mxi1-SRbeta form. Moreover, the Mxi1-SRalpha protein product, with its unique Sin3 interacting domain, has a greater affinity than its Mxi1-SRbeta counterpart for the Sin3 adapter proteins as well as an enhanced potential for transcriptional repression in transient reporter assays. Our identification of this novel Mxi1 isoform that results from alternative 5' exon usage adds an additional layer of complexity to the Mad/Mxi1 family. In addition, our findings warrant re-evaluation of mxi1 expression patterns on the cellular level and its status in human cancer samples, with a renewed focus on the distinct isoforms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15467743     DOI: 10.1038/sj.onc.1208107

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Alternative splicing regulates mouse embryonic stem cell pluripotency and differentiation.

Authors:  Nathan Salomonis; Christopher R Schlieve; Laura Pereira; Christine Wahlquist; Alexandre Colas; Alexander C Zambon; Karen Vranizan; Matthew J Spindler; Alexander R Pico; Melissa S Cline; Tyson A Clark; Alan Williams; John E Blume; Eva Samal; Mark Mercola; Bradley J Merrill; Bruce R Conklin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

2.  Induction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expression.

Authors:  Oona Delpuech; Beatrice Griffiths; Philip East; Abdelkader Essafi; Eric W-F Lam; Boudewijn Burgering; Julian Downward; Almut Schulze
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

3.  N-Myc differentially regulates expression of MXI1 isoforms in neuroblastoma.

Authors:  Michael B Armstrong; Rajen J Mody; D Christian Ellis; Adam B Hill; David A Erichsen; Daniel S Wechsler
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

4.  A mathematical model for short-term vs. long-term survival in patients with glioma.

Authors:  Jason B Nikas
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

5.  p73alpha isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells.

Authors:  Emilie Horvilleur; Matthieu Bauer; David Goldschneider; Xénia Mergui; Alix de la Motte; Jean Bénard; Sétha Douc-Rasy; David Cappellen
Journal:  Nucleic Acids Res       Date:  2008-06-25       Impact factor: 16.971

6.  Mxi1-0 regulates the growth of human umbilical vein endothelial cells through extracellular signal-regulated kinase 1/2 (ERK1/2) and interleukin-8 (IL-8)-dependent pathways.

Authors:  Weiling Wu; Zhenzhen Hu; Feng Wang; Hao Gu; Xiuqin Jiang; Jinjin Xu; Xi Zhan; Datong Zheng; Zhengdong Zhang
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

7.  Mxi1-0 Promotes Hypoxic Pulmonary Hypertension Via ERK/c-Myc-dependent Proliferation of Arterial Smooth Muscle Cells.

Authors:  Liang Dong; Xinning Liu; Bo Wu; Chengwei Li; Xiaomin Wei; Gulinuer Wumaier; Xiujuan Zhang; Jing Wang; Jingwen Xia; Yuanyuan Zhang; Ruzetuoheti Yiminniyaze; Ning Zhu; Jing Li; Daibing Zhou; Youzhi Zhang; Shuanghui Li; Junzhu Lv; Shengqing Li
Journal:  Front Genet       Date:  2022-03-23       Impact factor: 4.599

8.  Isoform-resolved mRNA profiling of ribosome load defines interplay of HIF and mTOR dysregulation in kidney cancer.

Authors:  Yoichiro Sugimoto; Peter J Ratcliffe
Journal:  Nat Struct Mol Biol       Date:  2022-09-12       Impact factor: 18.361

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.